Literature DB >> 17579167

Prevalence and significance of asymptomatic venous thromboembolic disease found on oncologic staging CT.

Carmel G Cronin1, Derek G Lohan, Maccon Keane, Clare Roche, Joseph M Murphy.   

Abstract

OBJECTIVE: The purpose of our study was to determine the prevalence of unsuspected venous thromboembolic disease--specifically, of pulmonary embolism (PE) and of inferior vena cava (IVC), iliac, and iliofemoral deep venous thromboses (DVTs)--in oncology patients on staging CT scans of the thorax, abdomen, and pelvis.
MATERIALS AND METHODS: Retrospective analysis was performed on 435 consecutive staging CT thorax, abdomen, and pelvis scans performed on a variety of oncology patients for the presence of venous thromboembolic disease. The patient group consisted of 198 men and 237 women who ranged in age from 20 to 79 years (mean, 55 years). Disease type, stage, concomitant surgery or chemoradiation therapy regimes, anticoagulation status, and 6-month clinical and radiologic follow-up findings were recorded.
RESULTS: We found a prevalence of 6.8% (23/339) unsuspected iliofemoral, 1.2% (4/339) unsuspected common iliac, and 0.3% (1/315) unsuspected IVC DVTs and 3.3% (13/397) unsuspected PEs occurring in patients with a wide range of malignancies. The overall prevalence of unsuspected venous thromboembolism (i.e., DVT, PE, or both) was 6.3% (25/397). DVT, PE, and venous thromboembolic disease were more common in inpatients (p = 0.002, 0.004, 0.023; relative risk [RR] = 1.6, 2.1, 1.4, respectively) and in those with advanced disease (p = 0.001, 0.01, 0.001; RR = 2.2, 1.8, 2.0, respectively).
CONCLUSION: Although there is a known increased risk of thromboembolism (DVT and PE) in oncology patients, many cases are not diagnosed, which can prove fatal. Staging CT simultaneously affords one sole investigation of the pulmonary, IVC, iliac, and upper femoral veins, thereby providing an important diagnostic opportunity. Assessment for DVT and PE is important when reviewing staging CT scans.

Entities:  

Mesh:

Year:  2007        PMID: 17579167     DOI: 10.2214/AJR.07.2067

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  27 in total

1.  Subsegmental pulmonary embolism: is the emperor still naked?

Authors:  Maurizio Zompatori; Domenico Attinà; Fabio Niro; Gualtiero Palareti
Journal:  Radiol Med       Date:  2013-07-15       Impact factor: 3.469

Review 2.  [Clinically relevant incidental cardiovascular findings in CT examinations].

Authors:  P Voigt; J Fahnert; D Schramm; A G Bach; T Kahn; A Surov
Journal:  Radiologe       Date:  2017-04       Impact factor: 0.635

3.  Unsuspected pulmonary thromboemboli: a continuing clinical challenge.

Authors:  Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2013

4.  High D-dimer levels are associated with poor prognosis in cancer patients.

Authors:  Cihan Ay; Daniela Dunkler; Robert Pirker; Johannes Thaler; Peter Quehenberger; Oswald Wagner; Christoph Zielinski; Ingrid Pabinger
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

5.  Prospective cohort study of cancer patients diagnosed with incidental venous thromboembolism on routine computed tomography scans.

Authors:  Carmen P Escalante; Gregory W Gladish; Wei Qiao; Ali Zalpour; Binara Assylbekova; Shuwei Gao; Kelechi A Olejeme; Marsha N Richardson; Maria E Suarez-Almazor
Journal:  Support Care Cancer       Date:  2017-01-09       Impact factor: 3.603

6.  Contrast enhanced chest-MDCT in oncologic patients. Prospective evaluation of the prevalence of incidental pulmonary embolism and added value of thin reconstructions.

Authors:  Silvia Tresoldi; Nicola Flor; Andrea Luciani; Maria Antonietta Lombardi; Bernardo Colombo; Gianpaolo Cornalba
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

Review 7.  Incidental venous thromboembolism: is anticoagulation indicated?

Authors:  Marcello Di Nisio; Marc Carrier
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

8.  Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients.

Authors:  E-M Reitter; C Ay; A Kaider; R Pirker; C Zielinski; G Zlabinger; I Pabinger
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

Review 9.  Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?

Authors:  A Maraveyas; M Johnson
Journal:  Br J Cancer       Date:  2009-06-02       Impact factor: 7.640

Review 10.  Epidemiology of cancer-related venous thromboembolism.

Authors:  Ted Wun; Richard H White
Journal:  Best Pract Res Clin Haematol       Date:  2009-03       Impact factor: 3.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.